Interviews/Contributions

Investor Insights: Rob Barmann – How Do You See Venture in MedTech Looking In 2023? (Part 3)

Share by Ken Dropiewski on

More in Interviews/Contributions:

Share this story

McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about what he’s expecting to see in the venture capital space in 2023.  

Ken has been in the cardiac, vascular, and interventional space for over 20 years. He is a Partner with McDermott + Bull Executive Search, recognized by Forbes as one of the industry's best with offices across North America and in Europe. Ken is hired by innovative cardiovascular device and biotech companies to help build their best teams possible at the executive level. Prior to search, Ken had an award winning commercial career at Boston Scientific and Johnson & Johnson to include such prestigious awards as President's Club, Ring Club, and Grand Awards. dropiewski@mbexec.com

Leave a Comment

Your email address will not be published. Required fields are marked *

*